ABSTRACT
Alcohol and tobacco consumption are closely correlated and published results on their association with breast cancer have not always allowed adequately for confounding between these exposures. Over 80% of the relevant information worldwide on alcohol and tobacco consumption and breast cancer were collated, checked and analysed centrally. Analyses included 58,515 women with invasive breast cancer and 95,067 controls from 53 studies. Relative risks of breast cancer were estimated, after stratifying by study, age, parity and, where appropriate, women's age when their first child was born and consumption of alcohol and tobacco. The average consumption of alcohol reported by controls from developed countries was 6.0 g per day, i.e. about half a unit/drink of alcohol per day, and was greater in ever-smokers than never-smokers, (8.4 g per day and 5.0 g per day, respectively). Compared with women who reported drinking no alcohol, the relative risk of breast cancer was 1.32 (1.19-1.45, P<0.00001) for an intake of 35-44 g per day alcohol, and 1.46 (1.33-1.61, P<0.00001) for >/=45 g per day alcohol. The relative risk of breast cancer increased by 7.1% (95% CI 5.5-8.7%; P<0.00001) for each additional 10 g per day intake of alcohol, i.e. for each extra unit or drink of alcohol consumed on a daily basis. This increase was the same in ever-smokers and never-smokers (7.1% per 10 g per day, P<0.00001, in each group). By contrast, the relationship between smoking and breast cancer was substantially confounded by the effect of alcohol. When analyses were restricted to 22 255 women with breast cancer and 40 832 controls who reported drinking no alcohol, smoking was not associated with breast cancer (compared to never-smokers, relative risk for ever-smokers=1.03, 95% CI 0.98-1.07, and for current smokers=0.99, 0.92-1.05). The results for alcohol and for tobacco did not vary substantially across studies, study designs, or according to 15 personal characteristics of the women; nor were the findings materially confounded by any of these factors. If the observed relationship for alcohol is causal, these results suggest that about 4% of the breast cancers in developed countries are attributable to alcohol. In developing countries, where alcohol consumption among controls averaged only 0.4 g per day, alcohol would have a negligible effect on the incidence of breast cancer. In conclusion, smoking has little or no independent effect on the risk of developing breast cancer; the effect of alcohol on breast cancer needs to be interpreted in the context of its beneficial effects, in moderation, on cardiovascular disease and its harmful effects on cirrhosis and cancers of the mouth, larynx, oesophagus and liver.
Subject(s)
Alcohol Drinking/adverse effects , Breast Neoplasms/etiology , Developing Countries , Smoking/adverse effects , Adult , Aged , Breast Neoplasms/epidemiology , Cardiovascular Diseases/etiology , Epidemiologic Studies , Female , Humans , Incidence , Middle Aged , Risk AssessmentABSTRACT
PURPOSE: The incidence of synchronous primary endometrial and ovarian cancer is 2- to 10-fold higher than that expected based on the incidence of each cancer alone. We sought to evaluate reasons for this in a case-control study. METHODS: We combined data on a maternal history of cancer and reproductive and menstrual factors from 56 women with synchronous multiple primary disease who had participated in three population-based studies of gynecologic cancer. For comparison, we analyzed the same information from 280 women with endometrial cancer alone, 280 with ovarian cancer alone, and 280 without a history of either cancer. RESULTS: The reduced risk of multiple primary disease associated with high parity (2 or more births vs 0: OR = 0.37, 95% Cl, 0.19-76) and long-term use of oral contraceptives (12 or more months vs none: OR = 0.60, 95% Cl, 0.24-1.5) tended to be more pronounced than that associated with endometrial cancer alone or with ovarian cancer alone. CONCLUSIONS: Though limited by relatively small numbers, our results suggest that the presence of some common etiologies is a basis for the unusually high co-occurrence of endometrial and ovarian cancers.
Subject(s)
Endometrial Neoplasms/etiology , Neoplasms, Multiple Primary/etiology , Ovarian Neoplasms/etiology , Reproductive History , Adult , Aged , Case-Control Studies , Endometrial Neoplasms/epidemiology , Estrogen Replacement Therapy/adverse effects , Female , Humans , Logistic Models , Middle Aged , Neoplasms, Multiple Primary/epidemiology , Odds Ratio , Ovarian Neoplasms/epidemiology , Risk Factors , Washington/epidemiologyABSTRACT
BACKGROUND: Adolescence is a high-risk period for the development of melanoma and nonmelanocytic skin cancers later in life. This study examines the prevalence and correlates of sun-protection practices among U.S. youth. METHODS: During July-October, 1998, a national, population-based telephone survey was conducted (N = 1,192 paired interviews of youth and their parents). Weighted prevalence and adjusted prevalence odds ratios and 95% confidence intervals were estimated. Multiple logistic regression analyses examined associations between sociodemographics, attitudes, and other modifiable correlates to specific behaviors. RESULTS: Routinely practiced sun-protection behaviors among youth on sunny days were wearing sunglasses (32%) or long pants (21%), staying in the shade (22%), and applying sunscreen (31%). Fifty-eight percent used a sunscreen with SPF > or =15 when at the beach or pool. Age, sex, and sun sensitivity were associated with substantial variation in some sun-protection behaviors. Factors associated with specific sun-protection behaviors included a lower appeal to tanning, a higher perceived benefit of sun protection, and information from family and friends about sun protection. CONCLUSION: Effective sun protection is practiced by less than one-third of U.S. youth. This baseline survey will help to monitor progress in skin cancer prevention in this critical age group in the future.
Subject(s)
Adolescent Behavior , Environmental Exposure/statistics & numerical data , Health Knowledge, Attitudes, Practice , Sunburn/prevention & control , Sunlight , Adolescent , Child , Environmental Exposure/prevention & control , Female , Humans , Logistic Models , Male , Odds Ratio , Skin Physiological Phenomena , Skin Pigmentation , United StatesABSTRACT
BACKGROUND: The American Cancer Society, the National Cancer Institute (NCI), the North American Association of Central Cancer Registries, and the Centers for Disease Control and Prevention, including the National Center for Health Statistics (NCHS), collaborate to provide an annual update on cancer occurrence and trends in the United States. This year's report contains a special feature that focuses on cancers with recent increasing trends. METHODS: From 1992 through 1998, age-adjusted rates and annual percent changes are calculated for cancer incidence and underlying cause of death with the use of NCI incidence and NCHS mortality data. Joinpoint analysis, a model of joined line segments, is used to examine long-term trends for the four most common cancers and for those cancers with recent increasing trends in incidence or mortality. Statistically significant findings are based on a P value of.05 by use of a two-sided test. State-specific incidence and death rates for 1994 through 1998 are reported for major cancers. RESULTS: From 1992 through 1998, total cancer death rates declined in males and females, while cancer incidence rates declined only in males. Incidence rates in females increased slightly, largely because of breast cancer increases that occurred in some older age groups, possibly as a result of increased early detection. Female lung cancer mortality, a major cause of death in women, continued to increase but more slowly than in earlier years. In addition, the incidence or mortality rate increased in 10 other sites, accounting for about 13% of total cancer incidence and mortality in the United States. CONCLUSIONS: Overall cancer incidence and death rates continued to decline in the United States. Future progress will require sustained improvements in cancer prevention, screening, and treatment.
Subject(s)
Neoplasms/epidemiology , Black or African American , American Cancer Society , Black People , Centers for Disease Control and Prevention, U.S. , Female , Humans , Incidence , Male , National Center for Health Statistics, U.S. , National Institutes of Health (U.S.) , Neoplasms/mortality , Registries , United States/epidemiology , White PeopleABSTRACT
OBJECTIVE: To investigate the hypothesis that tubal sterilization is associated with a reduced risk of breast cancer. METHODS: We examined this hypothesis in a large prospective study of US adults. After 14 years of mortality follow-up, 3837 deaths from breast cancer were observed in a cohort of 619,199 women who were cancer-free at study entry in 1982. RESULTS: Cox proportional hazards models (adjusted for multiple breast cancer risk factors) showed a significant inverse association between tubal sterilization and breast cancer mortality (adjusted rate ratio (RR) = 0.82, 95% confidence interval (CI) 0.70-0.96). Women who were sterilized before age 35 had a lower risk (adjusted RR = 0.69, 95% CI 0.53-0.88) than women who were sterilized at 35 years of age or older (adjusted RR = 0.92, 95% CI 0.75-1.13). Also, sterilizations performed before 1975 resulted in a lower risk (RR = 0.75, 95% CI 0.62-0.91) than those performed during or after 1975 (RR = 0.98, 95% CI 0.74-1.29), possibly reflecting the likelihood of greater tissue damage with earlier procedures. CONCLUSIONS: These results suggest that tubal sterilization may lower subsequent risk of breast cancer, especially among women who are sterilized at a relatively young age. Additional studies are needed to confirm or refute these findings.
Subject(s)
Breast Neoplasms/mortality , Cause of Death , Sterilization, Tubal/statistics & numerical data , Adult , Age Distribution , Aged , Breast Neoplasms/etiology , Cohort Studies , Confidence Intervals , Female , Humans , Incidence , Middle Aged , Proportional Hazards Models , Prospective Studies , Risk Assessment , Risk Factors , Sterilization, Tubal/adverse effects , United States/epidemiologyABSTRACT
OBJECTIVE: To investigate the hypothesis that alcohol consumption increases the risk of breast cancer mortality. METHODS: We examined breast cancer mortality in relation to self-reported alcohol consumption in women from the American Cancer Society Cancer Prevention Study (CPS)-II. After 14 years of follow-up, 1,442 eligible breast cancer deaths were observed among 242,010 women. Cox proportional hazards models were constructed for total alcohol consumption and for beer, wine, and liquor separately. RESULTS: Total alcohol consumption was associated with increased risk of fatal breast cancer among post- but not pre- or perimenopausal women. Even less than one drink/day was associated with up to a 30% increase in breast cancer mortality among postmenopausal women compared to non-drinkers (RR = 1.3, 95% CI: 1.1-1.6 for women drinking 0.26-<1 drink/day). When examined separately, consumption of beer, wine, and liquor each increased the risk of breast cancer among postmenopausal women. We found no evidence that alcohol consumption was more deleterious among women at high risk for breast cancer compared to average-risk women. CONCLUSION: This study adds to the evidence that postmenopausal women can reduce their risk of breast cancer by avoiding or minimizing their use of alcohol.
Subject(s)
Alcohol Drinking/adverse effects , Breast Neoplasms/etiology , Adult , Aged , Aged, 80 and over , Alcohol Drinking/epidemiology , Breast Neoplasms/epidemiology , Breast Neoplasms/mortality , Female , Humans , Middle Aged , Risk Factors , United States/epidemiologyABSTRACT
Women tend to fear breast cancer and thus overestimate their risk of developing it, have less concern about developing heart disease, and do not know that lung cancer is the major cause of cancer death. Death certificate data, consolidated into a national database by the National Center for Health Statistics, were used to compare age-specific mortality due to selected cardiovascular diseases and cancers among women who died in 1997 in the United States. The outcomes examined included underlying cause of death categorized as all circulatory system disease, cerebrovascular disease, and heart disease, including coronary and noncoronary disease, and as all cancers combined plus cancer of the lung, breast, and colon/rectum. In 1997, 500,703 women in the United States died from diseases of the circulatory system, including 370,357 deaths from heart disease. Most deaths from heart disease were due to coronary heart disease, which exceeded mortality from cerebrovascular disease at all ages except under age 40. In 1997, 258,463 women in the United States died from cancer, and before age 55, breast cancer death rates exceeded lung and colorectal cancer death rates. Mortality due to total heart disease exceeded breast and lung cancer mortality among women at all ages, but before age 55, when absolute death rates are low, breast cancer death rates exceeded those for coronary heart disease. In conclusion, aside from mortality due to all cancers combined and circulatory system disease, only accidents, which were not included in this study, and total heart disease caused more deaths than breast cancer before age 55.
Subject(s)
Breast Neoplasms/mortality , Cardiovascular Diseases/mortality , Cause of Death , Neoplasms/mortality , Women's Health , Adult , Age Distribution , Aged , Aged, 80 and over , Attitude to Health , Breast Neoplasms/etiology , Cardiovascular Diseases/etiology , Death Certificates , Female , Humans , Life Style , Middle Aged , National Center for Health Statistics, U.S. , Neoplasms/etiology , Population Surveillance , Risk Factors , Sex Distribution , United States/epidemiology , Women/psychologyABSTRACT
BACKGROUND: At a time when the population is aging and medical practices are rapidly changing, ongoing surveillance of surgical treatments for cancer is valuable for health services planning. METHODS: We used data from the National Hospital Discharge Survey for patients with discharge diagnoses of lung, prostate, female breast, and colorectal cancer during 1988-95 to estimate population-based rates and numbers of inpatient surgical procedures. RESULTS: In 1988-91, rates of lobectomy for lung cancer were significantly higher in males than females. By 1994-95, the male/female differences had largely disappeared due to increasing trends among females and decreasing trends among males. During 1988-95, surgeries on the large intestine for colorectal cancer, including right hemicolectomy and sigmoidectomy, decreased significantly, as did abdominoperineal resections of the rectum. Anterior resections of the rectum increased significantly. Radical prostatectomies for prostate cancer increased from 34,000 in 1988-89 to 104,000 in 1992-93 and then decreased to 87,000 in 1994-95; rates followed a similar pattern. Finally, the number and rates of inpatient mastectomies for female breast cancer decreased over the study period (from 219,000 to 180,000 and from 78.8 to 61.5 per 100,000, respectively). CONCLUSION: These trends in inpatient surgeries for the major cancers in the US probably reflect changes in disease occurrence and modified treatment recommendations.
Subject(s)
Neoplasms/epidemiology , Neoplasms/surgery , Age Distribution , Aged , Breast Neoplasms/epidemiology , Breast Neoplasms/surgery , Colectomy/statistics & numerical data , Colorectal Neoplasms/epidemiology , Colorectal Neoplasms/surgery , Female , Hospitalization/statistics & numerical data , Humans , Lung Neoplasms/epidemiology , Lung Neoplasms/surgery , Male , Mastectomy/statistics & numerical data , Middle Aged , Patient Discharge/statistics & numerical data , Pneumonectomy/statistics & numerical data , Prostatectomy/statistics & numerical data , Prostatic Neoplasms/epidemiology , Prostatic Neoplasms/surgery , Residence Characteristics , Sex Distribution , United States/epidemiologyABSTRACT
BACKGROUND: This annual report to the nation addresses progress in cancer prevention and control in the U.S. with a special section on colorectal cancer. This report is the joint effort of the American Cancer Society, the National Cancer Institute (NCI), the North American Association of Central Cancer Registries (NAACCR), and the Centers for Disease Control and Prevention (CDC), including the National Center for Health Statistics (NCHS). METHODS: Age-adjusted rates were based on cancer incidence data from the NCI and NAACCR and underlying cause of death as compiled by NCHS. Joinpoint analysis was based on NCI Surveillance, Epidemiology, and End Results (SEER) program incidence rates and NCHS death rates for 1973-1997. The prevalence of screening examinations for colorectal cancer was obtained from the CDC's Behavioral Risk Factor Surveillance System and the NCHS's National Health Interview Survey. RESULTS: Between 1990-1997, overall cancer incidence and death rates declined. Joinpoint analyses of cancer incidence and death rates confirmed the declines described in earlier reports. The incidence trends for colorectal cancer have shown recent steep declines for whites in contrast to a leveling off of the rates for blacks. State-to-state variations occurred in colorectal cancer screening prevalence as well as incidence and death rates. CONCLUSIONS: The continuing declines in overall cancer incidence and death rates are encouraging. However, a few of the top ten incidence or mortality cancer sites continued to increase or remained level. For many cancer sites, whites had lower incidence and mortality rates than blacks but higher rates than Hispanics, Asian and Pacific Islanders, and American Indians/Alaska Natives. The variations in colorectal cancer incidence and death rates by race/ethnicity, gender, age, and geographic area may be related to differences in risk factors, demographic characteristics, screening, and medical practice. New efforts currently are underway to increase awareness of screening benefits and treatment for colorectal cancer.
Subject(s)
Colorectal Neoplasms/epidemiology , Neoplasms/epidemiology , Breast Neoplasms/epidemiology , Bronchial Neoplasms/epidemiology , Colorectal Neoplasms/mortality , Female , Genital Neoplasms, Female/epidemiology , Humans , Leukemia/epidemiology , Lung Neoplasms/epidemiology , Lymphoma, Non-Hodgkin/epidemiology , Male , Melanoma/epidemiology , Neoplasms/diagnosis , Neoplasms/mortality , Pancreatic Neoplasms/epidemiology , Prostatic Neoplasms/epidemiology , Racial Groups , Skin Neoplasms/epidemiology , Survival Rate , United States/epidemiology , Urinary Bladder Neoplasms/epidemiologyABSTRACT
The Surveillance Research Program of the American Cancer Society's Department of Epidemiology and Surveillance Research reports its annual compilation of estimated cancer incidence, mortality, and survival data for the United States in the year 2000. After 70 years of increases, the recorded number of total cancer deaths among men in the US declined for the first time from 1996 to 1997. This decrease in overall male mortality is the result of recent down-turns in lung and bronchus cancer deaths, prostate cancer deaths, and colon and rectum cancer deaths. Despite decreasing numbers of deaths from female breast cancer and colon and rectum cancer, mortality associated with lung and bronchus cancer among women continues to increase. Lung cancer is expected to account for 25% of all female cancer deaths in 2000. This report also includes a summary of global cancer mortality rates using data from the World Health Organization.
Subject(s)
Neoplasms/epidemiology , Adult , Aged , American Cancer Society , Breast Neoplasms/epidemiology , Breast Neoplasms/mortality , Bronchial Neoplasms/epidemiology , Bronchial Neoplasms/mortality , Colonic Neoplasms/epidemiology , Colonic Neoplasms/mortality , Female , Global Health , Humans , Incidence , Lung Neoplasms/epidemiology , Lung Neoplasms/mortality , Male , Middle Aged , Neoplasms/mortality , Prostatic Neoplasms/epidemiology , Prostatic Neoplasms/mortality , Rectal Neoplasms/epidemiology , Rectal Neoplasms/mortality , SEER Program , Sex Factors , Survival Rate , United States/epidemiology , World Health OrganizationABSTRACT
The Surveillance Research Program of the American Cancer Society's Department of Epidemiology and Surveillance Research reports its 33rd annual compilation of cancer frequency, incidence, mortality, and survival data for the United States.
Subject(s)
Neoplasms/epidemiology , Adolescent , Black or African American/statistics & numerical data , Aged , American Cancer Society , Black People , Child , Child, Preschool , Ethnicity/statistics & numerical data , Female , Forecasting , Humans , Incidence , Infant , Male , Neoplasms/mortality , SEER Program , Survival Rate , United States/epidemiology , White People/statistics & numerical dataABSTRACT
BACKGROUND: The American Cancer Society, the National Cancer Institute (NCI), and the Centers for Disease Control and Prevention (CDC), including the National Center for Health Statistics (NCHS), provide the second annual report to the nation on progress in cancer prevention and control, with a special section on lung cancer and tobacco smoking. METHODS: Age-adjusted rates (using the 1970 U.S. standard population) were based on cancer incidence data from NCI and underlying cause of death data compiled by NCHS. The prevalence of tobacco use was derived from CDC surveys. Reported P values are two-sided. RESULTS: From 1990 through 1996, cancer incidence (-0.9% per year; P = .16) and cancer death (-0.6% per year; P = .001) rates for all sites combined decreased. Among the 10 leading cancer incidence sites, statistically significant decreases in incidence rates were seen in males for leukemia and cancers of the lung, colon/rectum, urinary bladder, and oral cavity and pharynx. Except for lung cancer, incidence rates for these cancers also declined in females. Among the 10 leading cancer mortality sites, statistically significant decreases in cancer death rates were seen for cancers of the male lung, female breast, the prostate, male pancreas, and male brain and, for both sexes, cancers of the colon/rectum and stomach. Age-specific analyses of lung cancer revealed that rates in males first declined at younger ages and then for each older age group successively over time; rates in females appeared to be in the early stages of following the same pattern, with rates decreasing for women aged 40-59 years. CONCLUSIONS: The declines in cancer incidence and death rates, particularly for lung cancer, are encouraging. However, unless recent upward trends in smoking among adolescents can be reversed, the lung cancer rates that are currently declining in the United States may rise again.
Subject(s)
Lung Neoplasms/epidemiology , Neoplasms/epidemiology , Smoking/epidemiology , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , American Cancer Society , Carcinoma, Non-Small-Cell Lung/epidemiology , Carcinoma, Small Cell/epidemiology , Centers for Disease Control and Prevention, U.S. , Female , Humans , Incidence , Lung Neoplasms/ethnology , Lung Neoplasms/etiology , Lung Neoplasms/mortality , Lung Neoplasms/prevention & control , Male , Middle Aged , National Institutes of Health (U.S.) , Neoplasms/ethnology , Neoplasms/mortality , Neoplasms/prevention & control , Prevalence , Retrospective Studies , SEER Program , Sex Distribution , Smoking/adverse effects , Smoking/ethnology , Smoking/mortality , Smoking Prevention , United States/epidemiologyABSTRACT
To examine the relation between family history of breast cancer in a mother or sister and a man's risk of fatal prostate cancer, we analyzed data from a prospective mortality study of adult men in the United States. During 12 years of follow-up, there were 3,141 deaths from prostate cancer in a cohort of 480,802 men who were cancer-free at study entry in 1982. Results from Cox proportional hazards models, adjusted for other risk factors, showed a modest increased risk of fatal prostate cancer associated with a family history of breast cancer (in the absence of a family history of prostate cancer) [rate ratio (RR) = 1.16; 95% confidence interval (CI) = 1.01-1.33]. The association was stronger among men younger than 65 years of age whose relatives were diagnosed with breast cancer before age 50 years (RR = 1.65; 95% CI = 0.88-3.10) and among Jewish men (RR = 1.73; 95% CI = 1.00-2.97). The increased risks observed in these subgroups may reflect genetic alterations underlying familial clustering of prostate and breast cancer.
Subject(s)
Breast Neoplasms/genetics , Prostatic Neoplasms/genetics , Prostatic Neoplasms/mortality , Aged , Breast Neoplasms/epidemiology , Cohort Studies , Family Health , Female , Humans , Male , Middle Aged , Odds Ratio , Pedigree , Proportional Hazards Models , Risk Factors , United States/epidemiologyABSTRACT
OBJECTIVE: To determine if home environmental hazards increase the risk of fall injury events among community-dwelling older persons. DESIGN: Population-based case-control study. SETTING: South Miami Beach, Florida. PARTICIPANTS: 270 persons aged 65 years and older who sought treatment at six area hospitals for injuries resulting from falls within the dwelling unit and 691 controls, frequency matched for sex and age, selected randomly from Health Care Financing Administration (Medicare) files. MAIN INDEPENDENT VARIABLES: The home environment of each person, assessed directly by interviewers using a standardized instrument. RESULTS: Environmental hazards were present in nearly all dwelling units. After adjusting for important confounding factors, most of these hazards were not associated with an increased risk of fall injury events among most older persons. Increasing numbers of tripping hazards, or total hazards in the dwelling unit, did not increase the risk of fall injury events, nor was there an increasing trend in risk. CONCLUSIONS: Current fall-prevention strategies of finding and changing all environmental hazards in all community-dwelling older persons' homes may have less potential effect than previously thought. The usefulness of grab bars, however, appears to warrant further evaluation.
Subject(s)
Accidental Falls/statistics & numerical data , Accidents, Home/statistics & numerical data , Environment Design , Accidental Falls/prevention & control , Accidents, Home/prevention & control , Aged , Aged, 80 and over , Case-Control Studies , Cross-Sectional Studies , Female , Humans , Incidence , Male , Risk , Wounds and Injuries/epidemiology , Wounds and Injuries/prevention & controlABSTRACT
Although survival rates are useful for monitoring progress in the early detection and treatment of cancer and are of particular interest to patients with new diagnoses, there are limited population-based estimates of long-term survival rates. We used data collected by the Surveillance, Epidemiology, and End Results Program for cases diagnosed during 1974-1991 and followed through 1992 to estimate relative survival at 5, 10, and 15 years after diagnosis of cancer of the breast, prostate, colon and rectum, and lung. Relative survival after diagnosis of breast and prostate cancer continued to decline up through 15 years after diagnosis, whereas survival after diagnosis of lung and colon or rectal cancer remained approximately constant after 5 and 10 years, respectively. Age-specific patterns of survival varied by site, stage, and demographics. Among patients with localized breast and prostate cancer, women who were younger than age 45 at breast cancer diagnosis and men who were 75 years and older at prostate cancer diagnosis had the poorest relative survival. Relative survival among lung cancer patients decreased with age at diagnosis, regardless of stage or demographics, and age-specific patterns of relative survival for patients with cancer of the colon and rectum differed according to race. Among white patients diagnosed with cancers of the colon and rectum, relative survival did not vary by age at diagnosis; among black patients older than 45 at diagnosis, relative survival decreased with age. This study provides population-based estimates of long-term survival and confirms black/white, male/female, and stage- and age-specific differences for the major cancers.
Subject(s)
Neoplasms/mortality , SEER Program , Adult , Black or African American/statistics & numerical data , Age Factors , Aged , Breast Neoplasms/epidemiology , Breast Neoplasms/mortality , Colorectal Neoplasms/epidemiology , Colorectal Neoplasms/mortality , Female , Follow-Up Studies , Humans , Lung Neoplasms/epidemiology , Lung Neoplasms/mortality , Male , Middle Aged , National Institutes of Health (U.S.) , Neoplasms/epidemiology , Prostatic Neoplasms/epidemiology , Prostatic Neoplasms/mortality , Sex Factors , Survival Rate , United States/epidemiology , White PeopleABSTRACT
BACKGROUND: The American Cancer Society, the National Cancer Institute (NCI), and the Centers for Disease Control and Prevention including the National Center for Health Statistics (NCHS) agreed to produce together an annual "Report Card" to the nation on progress related to cancer prevention and control in the U.S. METHODS: This report provides average annual percent changes in incidence and mortality during 1973-1990 and 1990-1995, plus age-adjusted cancer incidence and death rates for whites, blacks, Asians and Pacific Islanders, and Hispanics. Information on newly diagnosed cancer cases is based on data collected by NCI, and information on cancer deaths is based on underlying causes of death as reported to NCHS. RESULTS: For all sites combined, cancer incidence rates decreased on average 0.7% per year during 1990-1995 (P > 0.05), in contrast to an increasing trend in earlier years. Among the ten leading cancer incidence sites, a similar reversal in trends was apparent for the cancers of the lung, prostate, colon/rectum, urinary bladder, and leukemia; female breast cancer incidence rates increased significantly during 1973-1990 but were level during 1990-1995. Cancer death rates for all sites combined decreased on average 0.5% per year during 1990-1995 (P < 0.05) after significantly increasing 0.4% per year during 1973-1990. Death rates for the four major cancers (lung, female breast, prostate, and colon/rectum) decreased significantly during 1990-1995. CONCLUSIONS: These apparent successes are encouraging and signal the need to maximize cancer control efforts in the future so that even greater in-roads in reducing the cancer burden in the population are achieved.
Subject(s)
Epidemiologic Studies , Neoplasms/epidemiology , Neoplasms/mortality , Adolescent , Adult , Aged , Child , Child, Preschool , Ethnicity , Female , Humans , Incidence , Infant , Infant, Newborn , Male , Middle Aged , Racial Groups , Sex Factors , United States/epidemiologyABSTRACT
The Surveillance Research Program of the American Cancer Society's Department of Epidemiology and Surveillance reports its 32nd annual compilation of cancer incidence, mortality, and survival data for the United States and around the world.
Subject(s)
Neoplasms/epidemiology , Adult , Aged , Breast Neoplasms/epidemiology , Breast Neoplasms/mortality , Colonic Neoplasms/epidemiology , Colonic Neoplasms/mortality , Female , Global Health , Humans , Incidence , Lung Neoplasms/epidemiology , Lung Neoplasms/mortality , Male , Middle Aged , Neoplasms/mortality , Prostatic Neoplasms/epidemiology , Prostatic Neoplasms/mortality , Rectal Neoplasms/epidemiology , Rectal Neoplasms/mortality , SEER Program , Survival Rate , United States/epidemiology , World Health OrganizationABSTRACT
Key findings on cancer incidence and mortality are presented for five racial and ethnic groups in the United States--African Americans, American Indians, Asians and Pacific Islanders, Hispanics, and whites. Information on the prevalence of cancer risk factors and screening examinations among these racial and ethnic groups is also included.